RT Journal Article SR Electronic T1 177Lutetium Labelled Macroaggregated Albumin Imaging and Treatment Effect in Patient with Cystic Thyroid Nodule JF Journal of Nuclear Medicine Technology JO J. Nucl. Med. Technol. FD Society of Nuclear Medicine SP jnmt.119.226340 DO 10.2967/jnmt.119.226340 A1 Sait Sager A1 Aslan Aygün A1 Emre Karayel A1 Huseyin Pehlivanoglu A1 Kerim Sonmezoglu YR 2019 UL http://tech.snmjournals.org/content/early/2019/10/10/jnmt.119.226340.abstract AB There are number of different peptides and antibodies that have been labelled with Lutetium -177 and have been used in imaging and treatment for clinical usage. To our knowlodge, Lutetium-177 has never been labelled with MAA before. There was special effort exerted in the radiopharmacy laboratory of Istanbul University-Cerrahpaşa, to bind Lu-177 with MAA. We present a patient with a cystic thyroid nodule and SThere are number of different peptides or antibodies that have been labelled with 177Lutetium and have been used in imaging and treatment for clinical usage. To our knowlodge, 177Lutetium has never been labelled with macroaggregated albumin (MAA) before. There was special effort exerted in the radiopharmacy laboratory of Istanbul University-Cerrahpaşa, to bind 177Lu with MAA (LUTMA). We present 43-year-old male patient with a cystic thyroid nodule and SPECT/CT imaging after intranodular 177Lutetium labelled macroaggregated albumin injection and a treatment effect of this method.PECT/CT imaging after intranodular Lutetium-177 labeled macroaggregated albumin injection and a treatment effect of this method.